Drug Interaction Report
2 potential interactions and/or warnings found for the following 2 drugs:
- trichophyton skin test
- Zantac (ranitidine)
Interactions between your drugs
raNITIdine trichophyton skin test
Applies to: Zantac (ranitidine), trichophyton skin test
ADJUST DOSING INTERVAL: Systemic antihistamines may diminish the response to the trichophyton diagnostic skin test and lead to falsely insignificant or false-negative results. The proposed mechanism is inhibition of histamine release in the skin leading to suppression of the wheal and flare response. This interaction has been documented in numerous studies examining allergenic extracts and different antihistamines, but clinical data with the trichophyton diagnostic skin test are not readily available.
MANAGEMENT: The labeling for the trichophyton skin test recommends avoiding use of antihistamines for at least 24 hours prior to skin testing, though longer may be required depending on the specific antihistamine in question. Consultation with the labeling of the individual antihistamine as well as any relevant local and/or national guideline(s) is advisable.
References (2)
- (2007) "Product Information. Trichophyton Extracts (trichophyton skin test)." Allermed Laboratories Inc
- Bernstein L, Li JT, Bernstein DI, et al. (2008) "Allergy diagnostic testing: an updated practice parameter." Ann Allergy Asthma Immunol, 100, S1-148
Drug and food interactions
raNITIdine food
Applies to: Zantac (ranitidine)
H2 antagonists may reduce the clearance of nicotine. Cimetidine, 600 mg given twice a day for two days, reduced clearance of an intravenous nicotine dose by 30%. Ranitidine, 300 mg given twice a day for two days, reduced clearance by 10%. The clinical significance of this interaction is not known. Patients should be monitored for increased nicotine effects when using the patches or gum for smoking cessation and dosage adjustments should be made as appropriate.
References (1)
- Bendayan R, Sullivan JT, Shaw C, Frecker RC, Sellers EM (1990) "Effect of cimetidine and ranitidine on the hepatic and renal elimination of nicotine in humans." Eur J Clin Pharmacol, 38, p. 165-9
Therapeutic duplication warnings
No duplication warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
See also:
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Human Secretin
Human Secretin is used to stimulate pancreatic and gastrin secretions to aid in diagnosis. The FDA ...
R-Gene 10
R-Gene 10 is used for diagnosis and investigation, dietary supplementation
Thyrogen
Thyrogen is used for diagnosis and investigation, thyroid cancer
Learn more
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Check Interactions
To view an interaction report containing 4 (or more) medications, please sign in or create an account.
Save Interactions List
Sign in to your account to save this drug interaction list.